| |
| |
|
| Insider
Information: |
Almstead Neil Gregory |
| Relationship: |
|
| City: |
South Plainfield |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
86,202 |
|
|
Indirect Shares
|
4,576 |
|
|
| Direct
Value |
$3,134,305 |
|
|
|
Indirect Value
|
$166,383 |
|
|
| Total
Shares |
90,778 |
|
|
| Total
Value |
$3,300,688 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
29
|
|
Stock
price went up :
|
0
|
12
|
| Stock
price went down : |
0
|
17
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -317.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PTC Therapeutics, Inc. |
PTCT |
|
2024-02-15 |
86,202 |
2024-02-15 |
4,576 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
78 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTCT |
PTC Therapeutics, Inc. |
Chief Technical Ops Officer |
• – – |
2021-01-08 |
4 |
AS |
$69.00 |
$89,700 |
I/I |
(1,300) |
2,388 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
EVP Research Pharma Ops & Tech |
• – – |
2015-03-19 |
4 |
AS |
$69.36 |
$1,426,240 |
D/D |
(20,370) |
9,511 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
EVP, Research and CMC |
• – – |
2015-03-10 |
4 |
AS |
$70.71 |
$5,586 |
I/I |
(79) |
1,295 |
0 |
- |
|
78 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
